首页> 外文期刊>Oftal mokhirurgiya >Анализ клинической эффективности комбинированного лечения пеллюцидной дегенерации роговицы
【24h】

Анализ клинической эффективности комбинированного лечения пеллюцидной дегенерации роговицы

机译:角膜盆腔糖酸盐变性综合治疗临床疗效分析

获取原文
           

摘要

Purpose. The analysis of clinical efficacy of combined treatment of pellucid marginal degeneration (PMD), which included the implantation of intrastromal corneal ring segments (ICRS) and corneal collagen crosslinking (CXL). Material and methods. The analysis of results in the treatment was carried out in 12 eyes of 7 patients with PMD. A quantity and characteristic parameters of the implantable ICRS were determined using the own method of calculation based on keratotopography data. After 3 months, the procedure of local CXL was performed. The follow-up period was 1 year. In the process of observation the parameters of uncorrected (UCVA) and best corrected (BCVA) visualacuity, spherical equivalent and cylindrical component of subjective refraction were examined on the 1st day, 3 and 12 months after the start of treatment. At the same time the keratotopography data were analyzed – the cylindrical component and maximum keratometry and their dynamics. Keratopachymetry and endothelial cell density were examined before treatment, and 3 and 12 months after the treatment. Results. On the 1st day after the ICRS implantation, the refractive effect of operation varied from 7.0 to 10.5D (mean 7.6±2.1). A slightly decrease of refractive effect, which did not affect the functional results, was noted 3 months after operation before CXL. After CXL at the end of the follow-up period, the refraction of the cornea remained stable. An UCVA increase compared with the baseline by an average of 0.28±0.09, and for BCVA – by 0.09±0.05 was observed already on the 1st day after the ICRS implantation. One year after beginning of treatment, the UCVA increased by 0.32±0.18, BCVA – by 0.32±0.11 and amounted respectively 63.5±17.3% and 83.8±12.5% of retinal visual acuity before the treatment. At the same time, the parameters of keratopachymetry and endothelial cell density practically did not change after the performed treatment. Conclusion. The performed analysis showed a high efficiency and a safety of the combined treatment of PMD in the correction of refractive disorders, characteristic for this disease that allowed an increase in visual acuity of operated eyes and to ensure their stability for 1 year of follow-up period. Long-term results of proposed method require a further study.
机译:目的。薄裂解性边缘变性(PMD)结合治疗临床疗效分析,包括植入科内角膜环段(ICRS)和角膜胶原交联(CXL)。材料与方法。治疗结果的分析是在7例PMD患者的12名眼中进行。使用自身的基于角发术数据的计算方法确定可植入ICR的数量和特征参数。 3个月后,进行局部CXL的程序。随访期为1年。在治疗开始后的第1天,3和12个月内检查未校正(UCVA)和最佳校正(BCVA)的最佳校正(BCVA)的最佳校正(BCVA)的临床空间,球形当量和圆柱组分的参数。同时分析了角仔检测数据 - 圆柱形部件和最大角色测量和动力学。在治疗前检查了角膜外皮肌法和内皮细胞密度,治疗后3和12个月。结果。在ICRS植入后的第1天,操作的折射效果从7.0到10.5D(平均7.6±2.1)。在CXL之前的操作后3个月内注意到折射效果的折射率略微降低。在随访期结束时CXL后,角膜的折射保持稳定。与基线相比的UCVA增加平均值为0.28±0.09,并且对于在ICRS植入后的第1天已经观察到BCVA的0.09±0.05。开始治疗后一年,UCVA增加0.32±0.18,BCVA - 待遇在治疗前的视网膜视力的63.5±17.3%和83.8±12.3%和83.8±12.3%。同时,在进行所进行的处理后,角蛋白成像缩醛和内皮细胞密度的参数几乎不会改变。结论。所表演的分析显示出高效率和安全性PMD在屈光障碍校正中的矫正,这种疾病的特征允许允许经营眼睛的视力增加,并确保其稳定性为1年的随访时间。所提出的方法的长期结果需要进一步的研究。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号